Gemcitabine/Irinotecan/ZD1839 vs Paclitaxel/Carboplatin/Etoposide/ZD1839 in Carcinoma of Unknown Primary Site
Public ClinicalTrials.gov record NCT00193596. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Phase III Comparison of Gemcitabine/Irinotecan Followed by IRESSA Versus Paclitaxel/Carboplatin/Etoposide Followed by IRESSA in the First-Line Treatment of Patients With Carcinoma of Unknown Primary Site
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
In this randomized trial, we will investigate the activity and toxicity of two active regimens, gemcitabine/irinotecan and paclitaxel/carboplatin/Etoposide (both followed by ZD1839) in the first-line treatment of patients with carcinoma of unknown primary site.
Study identification
- NCT ID
- NCT00193596
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 198 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 2003 (Type not available)
- Primary completion
- Sep 2008 (Actual)
- Completion
- Jun 2009 (Actual)
- Last update posted
- May 3, 2013
2003 – 2009
United States locations
- U.S. sites
- 31
- U.S. states
- 19
- U.S. cities
- 31
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Northeast Alabama Regional Medical Center | Anniston | Alabama | 36207 | — |
| Clearview Cancer Institute | Huntsville | Alabama | 35805 | — |
| Southern Cancer Center, Sacred Heart Heath System Medical Oncology Group | Mobile | Alabama | 36608 | — |
| Northeast Arkansas Clinic | Jonesboro | Arkansas | 72401 | — |
| Tower Oncology | Beverly Hills | California | 90211 | — |
| Watson Clinic Center for Cancer Care and Research | Lakeland | Florida | 33805 | — |
| Mercy Hospital Miami | Miami | Florida | 33133 | — |
| Florida Hospital Cancer Institute | Orlando | Florida | 32804 | — |
| Phoebe Cancer Center | Albany | Georgia | 31701 | — |
| Northeast Georgia Medical Center | Gainesville | Georgia | 30501 | — |
| Wellstar Cancer Research | Marietta | Georgia | 30060 | — |
| Oncology Hematology Associates of SW Indiana | Evansville | Indiana | 47714 | — |
| Graves-Gilbert Clinic | Bowling Green | Kentucky | 42101 | — |
| Consultants in Blood Disorders and Cancer | Louisville | Kentucky | 40207 | — |
| Terrebonne General Medical Center | Houma | Louisiana | 70360 | — |
| Mercy Hospital | Portland | Maine | 04101 | — |
| Grand Rapids Clinical Oncology Program | Grand Rapids | Michigan | 49503 | — |
| St. Joseph Mercy Oakland Hospital, Cancer Center | Pontiac | Michigan | 48341 | — |
| Jackson Oncology Associates | Jackson | Mississippi | 39202 | — |
| Montana Cancer Institute Foundation | Missoula | Montana | 59802 | — |
| Methodist Cancer Center | Omaha | Nebraska | 68114 | — |
| Aultman Hospital | Canton | Ohio | 44710 | — |
| Oncology Hematology Care | Cincinnati | Ohio | 45242 | — |
| Consultants in Medical Oncology and Hematology | Drexel Hill | Pennsylvania | 19026 | — |
| Reading Hospital Regional Cancer Center | West Reading | Pennsylvania | 19612 | — |
| Spartanburg Regional Medical Center | Spartanburg | South Carolina | 29303 | — |
| Kingsport Hematology-Oncology | Kingsport | Tennessee | 37660 | — |
| Thompson Cancer Survival Center | Knoxville | Tennessee | 37916 | — |
| Tennessee Oncology, PLLC | Nashville | Tennessee | 37023 | — |
| South Texas Oncology and Hematology | San Antonio | Texas | 78258 | — |
| Cancer Outreach Associates | Abingdon | Virginia | 24211 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00193596, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 3, 2013 · Synced Oct 29, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00193596 live on ClinicalTrials.gov.